On this episode of The Fundamentals, we talked to Dr. Thomas J. Wang, dean of the University of Michigan Medical School, about the fundamental questions that have shaped his career and continue to drive biomedical research. Dean Wang discusses his work in cardiovascular research, the enduring impact of the Framingham Heart Study, the potential of AI and emerging health data, and the importance of collaboration between academia and industry. He also shares advice for the next generation of scientists and physicians and explains why sustained investment in biomedical research is essential to improving human health.

Cholesterol-lowering medicines called statins can reduce heart attack and stroke risk decades later; a study finds millions more people should be taking them.

Two days after his players recognized stroke symptoms at practice, a baseball and softball coach left the hospital with zero complications or lingering effects thanks to timely treatment.

Problems with the United States stroke transfer system are drastically reducing survivors’ chances of receiving critical treatment and increasing the likelihood that they will leave the hospital with a disability, a study suggests.

The recent study shows the biggest job gains were seen among low income adults with serious health problems whose health improved over time.

Stroke patients evaluated using telemedicine (telestroke) have higher odds of receiving essential treatment, yet it takes longer for them to be treated — potentially limiting the benefits, finds a Michigan Medicine.